Pittsburgh Journal of Technology Law & Policy
type: channel
description: The Pittsburgh Journal of Technology Law & Policy (JTLP) seeks to both celebrate and cultivate the spirit of innovation in the Pittsburgh region and beyond. We are a student-produced journal of contemporary legal topics involving technology of all kinds. The Journal publishes on a rolling basis, with each volume closing in the Spring. Since its first issue in Fall 2000, the journal has kept the legal community informed on emerging issues including entertainment and film, patent application, information privacy, social media networks, cyberspace law, and other intellectual property and technology queries. We welcome submissions of manuscripts from legal scholars, practicing attorneys and anyone who is interested in submitting appealing, timely, technology-related material. In addition, submissions on topics linked specifically to the Western District of Pennsylvania are of particular interest to the Journal and are very well-regarded. University of Pittsburgh School of Law<!-- [if gte mso 9]><xml> <o:OfficeDocumentSettings> <o:AllowPNG ></o:AllowPNG> </o:OfficeDocumentSettings> </xml><![endif]--><!-- [if gte mso 9]><xml> <w:WordDocument> <w:View>Normal</w:View> <w:Zoom>0</w:Zoom> <w:TrackMoves ></w:TrackMoves> <w:TrackFormatting ></w:TrackFormatting> <w:PunctuationKerning ></w:PunctuationKerning> <w:ValidateAgainstSchemas ></w:ValidateAgainstSchemas> <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid> <w:IgnoreMixedContent>false</w:IgnoreMixedContent> <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText> <w:DoNotPromoteQF ></w:DoNotPromoteQF> <w:LidThemeOther>EN-US</w:LidThemeOther> <w:LidThemeAsian>X-NONE</w:LidThemeAsian> <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript> <w:Compatibility> <w:BreakWrappedTables ></w:BreakWrappedTables> <w:SnapToGridInCell ></w:SnapToGridInCell> <w:WrapTextWithPunct ></w:WrapTextWithPunct> <w:UseAsianBreakRules ></w:UseAsianBreakRules> <w:DontGrowAutofit ></w:DontGrowAutofit> <w:SplitPgBreakAndParaMark ></w:SplitPgBreak…
publisher: University Library System, University of Pittsburgh
language: en-US
publication name: Pittsburgh Journal of Technology Law & Policy
issn: 2164-800X
copyright: Authors who publish with this journal agree to the following terms: The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution. Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work. The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons 4.0 License (Attribution-Noncommercial-No Derivative Works), or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions: Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; Noncommercial—other users (including Publisher) may not use this Work for commercial purposes; No Derivative Works—other users (including Publisher) may not alter, transform, or build upon this Work,with the understanding that any of the above conditions can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license. The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post online a pre-publication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlie…
items: The Use of Race in Medical Artificial Intelligence
items: For Profit or For Health? It is Time to Reckon With the Current Pharmaceutical Landscape Through a Systematic Analysis of Monoclonal Anitbodies
items: Volume XXI Issue 2 Front Matter

The Use of Race in Medical Artificial Intelligence
type: item
description: The proliferated use of medical algorithms in health care has brought about medical innovation and improvements; however, there is a cost to a prevalent use of artificial intelligence in health care—exacerbating racism in the medicine. This Article examines the use of race in medical algorithms. Part II describes the development of medical AI, including its advantages and disadvantages. Part III focuses on how the use of medical algorithms may embed racism into our health care system. Part IV describes the FDA’s current regulations on medical AI. The Article concludes by advocating for legislation and regulations that work to reduce racial bias in medical algorithms.
creator: Priya Desai
rights: Copyright (c) 2021 Priya Desai
date: 2021-08-26
publication date: 2021-08-26
volume: 21
number: 2
doi: 10.5195/tlp.2021.253

For Profit or For Health? It is Time to Reckon With the Current Pharmaceutical Landscape Through a Systematic Analysis of Monoclonal Anitbodies
type: item
description: Soaring drug prices are one of the greatest challenges facing the American healthcare system today. Major contributing factors include the extended use of market exclusivity granted by the FDA and the abuse of the Orphan Drug Act beyond its original purpose. This Note will discuss the regulatory and legislative history of the FDA from its inception to its current state and use a comprehensive analysis of monoclonal antibodies to highlight the practical effects high drug prices have on patient care. Finally, this Note will provide recommendations to shift the regulatory and legislative approach surrounding the FDA away from favoring innovation to supporting competition in the drug market, thus improving accessibility.
creator: Alexander Snyder
rights: Copyright (c) 2021 Alexander Snyder
date: 2021-08-26
publication date: 2021-08-26
volume: 21
number: 2
doi: 10.5195/tlp.2021.251

Volume XXI Issue 2 Front Matter
type: item
description: Front Matter
creator: Pittsburgh Journal of Technology Law and Policy
rights: Copyright (c) 2021
date: 2021-09-21
publication date: 2021-09-21
volume: 21
number: 2
doi: 10.5195/tlp.2021.254